These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

642 related items for PubMed ID: 10582691

  • 1. Loss of KAI1 expression in the progression of colorectal cancer.
    Lombardi DP, Geradts J, Foley JF, Chiao C, Lamb PW, Barrett JC.
    Cancer Res; 1999 Nov 15; 59(22):5724-31. PubMed ID: 10582691
    [Abstract] [Full Text] [Related]

  • 2. KAI1 metastasis suppressor protein is down-regulated during the progression of human endometrial cancer.
    Liu FS, Dong JT, Chen JT, Hsieh YT, Ho ES, Hung MJ, Lu CH, Chiou LC.
    Clin Cancer Res; 2003 Apr 15; 9(4):1393-8. PubMed ID: 12684410
    [Abstract] [Full Text] [Related]

  • 3. KAI1 protein is down-regulated during the progression of human breast cancer.
    Yang X, Wei L, Tang C, Slack R, Montgomery E, Lippman M.
    Clin Cancer Res; 2000 Sep 15; 6(9):3424-9. PubMed ID: 10999724
    [Abstract] [Full Text] [Related]

  • 4. Frequent down-regulation and lack of mutation of the KAI1 metastasis suppressor gene in epithelial ovarian carcinoma.
    Liu FS, Dong JT, Chen JT, Hsieh YT, Ho ES, Hung MJ.
    Gynecol Oncol; 2000 Jul 15; 78(1):10-5. PubMed ID: 10873402
    [Abstract] [Full Text] [Related]

  • 5. KAI1, a new metastasis suppressor gene, is reduced in metastatic hepatocellular carcinoma.
    Guo XZ, Friess H, Di Mola FF, Heinicke JM, Abou-Shady M, Graber HU, Baer HU, Zimmermann A, Korc M, Büchler MW.
    Hepatology; 1998 Dec 15; 28(6):1481-8. PubMed ID: 9828210
    [Abstract] [Full Text] [Related]

  • 6. Down-regulation of the KAI1 metastasis suppressor gene during the progression of human prostatic cancer infrequently involves gene mutation or allelic loss.
    Dong JT, Suzuki H, Pin SS, Bova GS, Schalken JA, Isaacs WB, Barrett JC, Isaacs JT.
    Cancer Res; 1996 Oct 01; 56(19):4387-90. PubMed ID: 8813131
    [Abstract] [Full Text] [Related]

  • 7. Frequent downregulation of the KAI1(CD82) metastasis suppressor protein in human cancer cell lines.
    White A, Lamb PW, Barrett JC.
    Oncogene; 1998 Jun 18; 16(24):3143-9. PubMed ID: 9671393
    [Abstract] [Full Text] [Related]

  • 8. Expression of the KAI1 metastasis suppressor gene in non-metastatic versus metastatic human colorectal cancer.
    Yang JL, Jackson P, Yu Y, Russell PJ, Markovic B, Crowe PJ.
    Anticancer Res; 2002 Jun 18; 22(6A):3337-42. PubMed ID: 12530084
    [Abstract] [Full Text] [Related]

  • 9. Motility-related protein (MRP-1/CD9) and KAI1/CD82 expression inversely correlate with lymph node metastasis in oesophageal squamous cell carcinoma.
    Uchida S, Shimada Y, Watanabe G, Li ZG, Hong T, Miyake M, Imamura M.
    Br J Cancer; 1999 Mar 18; 79(7-8):1168-73. PubMed ID: 10098753
    [Abstract] [Full Text] [Related]

  • 10. Relationship between expression of the KAI1 metastasis suppressor and other markers of advanced bladder cancer.
    Ow K, Delprado W, Fisher R, Barrett J, Yu Y, Jackson P, Russell PJ.
    J Pathol; 2000 May 18; 191(1):39-47. PubMed ID: 10767717
    [Abstract] [Full Text] [Related]

  • 11. Downregulation of KAI1 mRNA in localised prostate cancer and its bony metastases does not correlate with p53 overexpression.
    Jackson P, Ow K, Yardley G, Delprado W, Quinn DI, Yang JL, Russell PJ.
    Prostate Cancer Prostatic Dis; 2003 May 18; 6(2):174-81. PubMed ID: 12806379
    [Abstract] [Full Text] [Related]

  • 12. Correlation of KAI1/CD82 gene expression with good prognosis in patients with non-small cell lung cancer.
    Adachi M, Taki T, Ieki Y, Huang CL, Higashiyama M, Miyake M.
    Cancer Res; 1996 Apr 15; 56(8):1751-5. PubMed ID: 8620488
    [Abstract] [Full Text] [Related]

  • 13. KAI1/CD82 expression as a prognosic factor in sporadic colorectal cancer.
    Muneyuki T, Watanabe M, Yamanaka M, Shiraishi T, Isaji S.
    Anticancer Res; 2001 Apr 15; 21(5):3581-7. PubMed ID: 11848527
    [Abstract] [Full Text] [Related]

  • 14. CD82, and CD63 in thyroid cancer.
    Chen Z, Mustafa T, Trojanowicz B, Brauckhoff M, Gimm O, Schmutzler C, Köhrle J, Holzhausen HJ, Kehlen A, Klonisch T, Finke R, Dralle H, Hoang-Vu C.
    Int J Mol Med; 2004 Oct 15; 14(4):517-27. PubMed ID: 15375577
    [Abstract] [Full Text] [Related]

  • 15. KAI1 is unchanged in metastatic and nonmetastatic esophageal and gastric cancers.
    Guo XZ, Friess H, Maurer C, Berberat P, Tang WH, Zimmermann A, Naef M, Graber HU, Korc M, Büchler MW.
    Cancer Res; 1998 Feb 15; 58(4):753-8. PubMed ID: 9485031
    [Abstract] [Full Text] [Related]

  • 16. KAI1 COOH-terminal interacting tetraspanin (KITENIN), a member of the tetraspanin family, interacts with KAI1, a tumor metastasis suppressor, and enhances metastasis of cancer.
    Lee JH, Park SR, Chay KO, Seo YW, Kook H, Ahn KY, Kim YJ, Kim KK.
    Cancer Res; 2004 Jun 15; 64(12):4235-43. PubMed ID: 15205336
    [Abstract] [Full Text] [Related]

  • 17. Suppression of invasive properties of colon cancer cells by a metastasis suppressor KAI1 gene.
    Takaoka A, Hinoda Y, Satoh S, Adachi Y, Itoh F, Adachi M, Imai K.
    Oncogene; 1998 Mar 15; 16(11):1443-53. PubMed ID: 9525743
    [Abstract] [Full Text] [Related]

  • 18. KAI1 expression is up-regulated in early pancreatic cancer and decreased in the presence of metastases.
    Guo X, Friess H, Graber HU, Kashiwagi M, Zimmermann A, Korc M, Büchler MW.
    Cancer Res; 1996 Nov 01; 56(21):4876-80. PubMed ID: 8895737
    [Abstract] [Full Text] [Related]

  • 19. Downregulation of KAI1 metastasis suppressor protein is associated with a dismal prognosis in epithelial ovarian cancer.
    Schindl M, Birner P, Breitenecker G, Oberhuber G.
    Gynecol Oncol; 2001 Nov 01; 83(2):244-8. PubMed ID: 11606078
    [Abstract] [Full Text] [Related]

  • 20. Loss of KAI1 expression in gastric cancer.
    Tsutsumi S, Shimura T, Morinaga N, Mochiki E, Asao T, Kuwano H.
    Hepatogastroenterology; 2005 Nov 01; 52(61):281-4. PubMed ID: 15783050
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.